The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trident Texofab Ltd & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011. This filing has been made by Trident Texofab Ltd along with Persons Acting in Concert (PACs), which typically indicates a change in their shareholding or voting rights in the company that crosses the regulatory reporting thresholds. The exact nature of the transaction—whether it is an acquisition or disposal—is not specified in the headline. No specific percentage change, deal value, or direction (buy/sell) is mentioned in the available information. Investors should check the full disclosure on the BSE portal for the exact details of the change in shareholding.
SAST disclosures signal a meaningful change in promoter-group or PAC shareholding, which can influence stock price sentiment depending on whether shares were bought or sold. Retail investors should review the detailed filing to understand whether promoter entities are increasing or reducing their stake before drawing conclusions.